NABC1 (BCAS1) (NM_003657) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC223329L1V

  • LentiORF®

Lenti ORF particles, BCAS1 (Myc-DDK tagged) - Human breast carcinoma amplified sequence 1 (BCAS1), 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP

Lentiviral Particles: DDK DDK w/ Puro mGFP mGFP w/ Puro


Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50

USD 1,365.00

2 Weeks*

Size
    • 200 ul

Product Images

Frequently bought together (3)
Lenti ORF control particles of pLenti-C-Myc-DDK, >10^7 TU/mL, 0.5 mL
    • 500 ul

USD 365.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

USD 671.00


Rabbit Polyclonal BCAS1 Antibody
    • 100 ug

USD 570.00

Other products for "NABC1"

Specifications

Product Data
Type Human Tagged ORF Clone Lentiviral Particle
Tag Myc-DDK
Symbol NABC1
Synonyms AIBC1; NABC1; PMES-2
Mammalian Cell Selection None
Vector pLenti-C-Myc-DDK
ACCN NM_003657
ORF Size 1752 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC223329).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_003657.1
RefSeq Size 3475 bp
RefSeq ORF 1755 bp
Locus ID 8537
UniProt ID O75363
Cytogenetics 20q13.2
MW 61.7 kDa
Gene Summary This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene. [provided by RefSeq, Apr 2016]

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.